ACEMETACIN

DRUG3 trials

Sponsors

Cannaxan GmbH, Apurano Pharmaceuticals GmbH, St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr, Chinese PLA General Hospital

Conditions

Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)Axial SpondyloarthritisAxial Spondyloarthritis, Non-RadiographicChronic back pain

Phase 3

Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain

SuspendedCTIS2022-502151-54-00

Cannaxan GmbH, Apurano Pharmaceuticals GmbHChronic back pain

Start: 2023-11-02Target: 558Updated: 2024-11-22

Phase 4

Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis

RecruitingCTIS2024-513213-13-00

St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-RuhrAxial Spondyloarthritis

Start: 2025-03-13Target: 100Updated: 2025-09-06

Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study

Not yet recruitingNCT07582146

Chinese PLA General HospitalAnkylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), Axial Spondyloarthritis, Axial Spondyloarthritis, Non-Radiographic

Start: 2026-04-01End: 2026-12-01Target: 150Updated: 2026-05-12